Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Paul L DefordKettering Laboratory, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, 160 Panzeca Way, Cincinnati, OH 45267-0056, USA.
Andrew P VonHandorfCenter for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.ORCID 0000-0003-2495-2324
Brian G HuntDepartment of Cancer Biology, Vontz Center for Molecular Studies, University of Cincinnati College of Medicine, 3125 Eden Avenue, P.O. Box 670521, Cincinnati, OH 45267-0521, USA.ORCID 0000-0003-4155-730X
Simran VenkatramanKettering Laboratory, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, 160 Panzeca Way, Cincinnati, OH 45267-0056, USA.ORCID 0000-0002-2037-0952
Susan E WaltzDepartment of Cancer Biology, Vontz Center for Molecular Studies, University of Cincinnati College of Medicine, 3125 Eden Avenue, P.O. Box 670521, Cincinnati, OH 45267-0521, USA.ORCID 0000-0003-3572-4642
Katherine A BurnsKettering Laboratory, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, 160 Panzeca Way, Cincinnati, OH 45267-0056, USA.
Susan KasperKettering Laboratory, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, 160 Panzeca Way, Cincinnati, OH 45267-0056, USA.
Funding
Training Program in Cancer TherapeuticsT32CA117846 · NCI · UNIVERSITY OF CINCINNATI · PI PRICE, CAROLYN M, TAKIAR, VINITA · 2006 to 2022
$6.5M
Defining genetic and metabolic requirements of aggressive breast cancerR01CA239697 · NCI · UNIVERSITY OF CINCINNATI · PI WALTZ, SUSAN E, WELLS, SUSANNE I · 2020 to 2024
$2.4M
BLRD VA I01 BX000803Department of Defense Idea Development Award W81XWH-17-1-0601Department of Defense Idea Development Awards HT94252410242 to SKDepartment of Veteran's Affairs Research Service, Cincinnati Veteran's Affairs Medical Center I01BX000803NCI NIH HHS R01 CA239697NCI NIH HHS T32 CA117846NIH HHS 1F31CA228373-22NIH HHS 1R01CA239696-23NIH HHS 1T32CA117846-23
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro. · full record | OpenQuestion